Drug application

NEO-MEDROL ACETATE (METHYLPREDNISOLONE ACETATE, NEOMYCIN SULFATE)

Drugs@FDA ANDA 060611 · PHARMACIA AND UPJOHN

Key facts

Drug name NEO-MEDROL ACETATE
Active ingredients METHYLPREDNISOLONE ACETATE, NEOMYCIN SULFATE
Application type ANDA
Application number 060611
Company PHARMACIA AND UPJOHN
Dosage forms CREAM, TOPICAL
Strength 1%;EQ 3.5MG BASE/GM
Marketing status Discontinued
Reference listed drug No
Latest submission status date Dec 7, 1964

At a glance

  • 1–9 Submissions
  • 1–9 Supplements
  • None Label versions
  • 1–9 Products
  • None Therapeutic equivalents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA applications

Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA

Browse all Drugs@FDA applications